Weekly update
Companies
AI-cruiter
Recruiting service
Sigilon Therapeutics
Founded:
2016
Location:
Cambridge, MA
Employee range:
50 - 200
Clinical stage:
RD
Therapy area:
Diabetes (1)
Drug types:
END, IMM, NEU, GEN, HEP
Lead product:
SIG-002
Product link:
http://sigilon.com/pipeline/
Funding:
$145M IPO Dec 2020; $80M Mar 2020; $23.5M A Jun 2017
sigilon.com
linkedin.com
job board
Short description:
Living Therapeutics
Drug notes:
SIG-XXX RD MPS-1, CNS condition; SIG-007 RD Fabry disease; SIG-018 RD MPS-2, CNS condition; SIG-020 RD MPS-6; undisclosed RD liver disease
Long description:
Contact us to add description.
Jobs:
Main
Home
Weekly update
Companies
AI-cruiter
Recruiting service
© 2023 Work In Biotech LLC
Personal data
Terms of Service
Privacy Policy
Contact: recruit@workinbiotech.com